Barings’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-25,190	Closed	-$3.1M	–	732
2018 Q3	$3.1M	Buy	+25,190	New	+$3.1M	0.04%	255